Brian M. Wolpin, MD, on Performance of a Blood-Based Test for the Detection of Multiple Cancers

January 29, 2020 By The ASCO Post

Brian M. Wolpin, MD, of Dana-Farber Cancer Institute, discusses a noninvasive blood test evaluating methylation of circulating free DNA. In his study, the blood test detected multiple gastrointestinal cancers at a sensitivity of approximately 81% and a prespecified specificity of > 99%. It also accurately localized the tissue of origin across more than 20 cancer types (Abstract 283).

Related Content